Global Artificial Pancreas Devices Systems Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report presents an overview of global market for Artificial Pancreas Devices Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Pancreas Devices Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Pancreas Devices Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Pancreas Devices Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Pancreas Devices Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Pancreas Devices Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
Artificial Pancreas Devices Systems segment by Company
1. To analyze and research the global Artificial Pancreas Devices Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Artificial Pancreas Devices Systems market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Artificial Pancreas Devices Systems significant trends, drivers, influence factors in global and regions.
6. To analyze Artificial Pancreas Devices Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artificial Pancreas Devices Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Pancreas Devices Systems industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Artificial Pancreas Devices Systems in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report presents an overview of global market for Artificial Pancreas Devices Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Pancreas Devices Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Pancreas Devices Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Pancreas Devices Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Pancreas Devices Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Pancreas Devices Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc.
Artificial Pancreas Devices Systems segment by Company
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
- Hospitals
- Clinics
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Artificial Pancreas Devices Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Artificial Pancreas Devices Systems market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Artificial Pancreas Devices Systems significant trends, drivers, influence factors in global and regions.
6. To analyze Artificial Pancreas Devices Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artificial Pancreas Devices Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Pancreas Devices Systems industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Artificial Pancreas Devices Systems in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Pancreas Devices Systems Sales Value (2019-2030)
1.2.2 Global Artificial Pancreas Devices Systems Sales Volume (2019-2030)
1.2.3 Global Artificial Pancreas Devices Systems Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY COMPANY
3.1 Global Artificial Pancreas Devices Systems Company Revenue Ranking in 2023
3.2 Global Artificial Pancreas Devices Systems Revenue by Company (2019-2024)
3.3 Global Artificial Pancreas Devices Systems Sales Volume by Company (2019-2024)
3.4 Global Artificial Pancreas Devices Systems Average Price by Company (2019-2024)
3.5 Global Artificial Pancreas Devices Systems Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Artificial Pancreas Devices Systems Company Manufacturing Base & Headquarters
3.7 Global Artificial Pancreas Devices Systems Company, Product Type & Application
3.8 Global Artificial Pancreas Devices Systems Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY TYPE
4.1 Artificial Pancreas Devices Systems Type Introduction
4.1.1 Threshold Suspended Device Systems
4.1.2 Hybrid Closed-loop APDS
4.1.3 Other Systems
4.2 Global Artificial Pancreas Devices Systems Sales Volume by Type
4.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Type (2019-2030)
4.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2019-2030)
4.3 Global Artificial Pancreas Devices Systems Sales Value by Type
4.3.1 Global Artificial Pancreas Devices Systems Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Pancreas Devices Systems Sales Value by Type (2019-2030)
4.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Type (2019-2030)
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY APPLICATION
5.1 Artificial Pancreas Devices Systems Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Artificial Pancreas Devices Systems Sales Volume by Application
5.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Application (2019-2030)
5.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Sales Value by Application
5.3.1 Global Artificial Pancreas Devices Systems Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Artificial Pancreas Devices Systems Sales Value by Application (2019-2030)
5.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application (2019-2030)
6 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY REGION
6.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Artificial Pancreas Devices Systems Sales by Region (2019-2030)
6.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019-2024
6.2.2 Global Artificial Pancreas Devices Systems Sales by Region (2025-2030)
6.3 Global Artificial Pancreas Devices Systems Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Artificial Pancreas Devices Systems Sales Value by Region (2019-2030)
6.4.1 Global Artificial Pancreas Devices Systems Sales Value by Region: 2019-2024
6.4.2 Global Artificial Pancreas Devices Systems Sales Value by Region (2025-2030)
6.5 Global Artificial Pancreas Devices Systems Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.6.2 North America Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.7.2 Europe Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.8.2 Asia-Pacific Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.9.2 Latin America Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.10.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
7 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY COUNTRY
7.1 Global Artificial Pancreas Devices Systems Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Artificial Pancreas Devices Systems Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Artificial Pancreas Devices Systems Sales by Country (2019-2030)
7.3.1 Global Artificial Pancreas Devices Systems Sales by Country (2019-2024)
7.3.2 Global Artificial Pancreas Devices Systems Sales by Country (2025-2030)
7.4 Global Artificial Pancreas Devices Systems Sales Value by Country (2019-2030)
7.4.1 Global Artificial Pancreas Devices Systems Sales Value by Country (2019-2024)
7.4.2 Global Artificial Pancreas Devices Systems Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.5.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.6.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.7.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.8.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.9.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.10.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.11.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.12.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.13.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.14.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.15.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.16.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.17.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.18.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.19.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.20.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.21.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.22.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.23.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Bigfoot Biomedical
8.2.1 Bigfoot Biomedical Comapny Information
8.2.2 Bigfoot Biomedical Business Overview
8.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
8.2.5 Bigfoot Biomedical Recent Developments
8.3 Beta Bionics
8.3.1 Beta Bionics Comapny Information
8.3.2 Beta Bionics Business Overview
8.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
8.3.5 Beta Bionics Recent Developments
8.4 Admetsys
8.4.1 Admetsys Comapny Information
8.4.2 Admetsys Business Overview
8.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
8.4.5 Admetsys Recent Developments
8.5 Insulet
8.5.1 Insulet Comapny Information
8.5.2 Insulet Business Overview
8.5.3 Insulet Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
8.5.5 Insulet Recent Developments
8.6 Tandem Diabetes Care
8.6.1 Tandem Diabetes Care Comapny Information
8.6.2 Tandem Diabetes Care Business Overview
8.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
8.6.5 Tandem Diabetes Care Recent Developments
8.7 Defymed
8.7.1 Defymed Comapny Information
8.7.2 Defymed Business Overview
8.7.3 Defymed Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
8.7.5 Defymed Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Artificial Pancreas Devices Systems Value Chain Analysis
9.1.1 Artificial Pancreas Devices Systems Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Artificial Pancreas Devices Systems Sales Mode & Process
9.2 Artificial Pancreas Devices Systems Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Artificial Pancreas Devices Systems Distributors
9.2.3 Artificial Pancreas Devices Systems Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Pancreas Devices Systems Sales Value (2019-2030)
1.2.2 Global Artificial Pancreas Devices Systems Sales Volume (2019-2030)
1.2.3 Global Artificial Pancreas Devices Systems Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY COMPANY
3.1 Global Artificial Pancreas Devices Systems Company Revenue Ranking in 2023
3.2 Global Artificial Pancreas Devices Systems Revenue by Company (2019-2024)
3.3 Global Artificial Pancreas Devices Systems Sales Volume by Company (2019-2024)
3.4 Global Artificial Pancreas Devices Systems Average Price by Company (2019-2024)
3.5 Global Artificial Pancreas Devices Systems Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Artificial Pancreas Devices Systems Company Manufacturing Base & Headquarters
3.7 Global Artificial Pancreas Devices Systems Company, Product Type & Application
3.8 Global Artificial Pancreas Devices Systems Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY TYPE
4.1 Artificial Pancreas Devices Systems Type Introduction
4.1.1 Threshold Suspended Device Systems
4.1.2 Hybrid Closed-loop APDS
4.1.3 Other Systems
4.2 Global Artificial Pancreas Devices Systems Sales Volume by Type
4.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Type (2019-2030)
4.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2019-2030)
4.3 Global Artificial Pancreas Devices Systems Sales Value by Type
4.3.1 Global Artificial Pancreas Devices Systems Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Pancreas Devices Systems Sales Value by Type (2019-2030)
4.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Type (2019-2030)
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY APPLICATION
5.1 Artificial Pancreas Devices Systems Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Artificial Pancreas Devices Systems Sales Volume by Application
5.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Application (2019-2030)
5.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Sales Value by Application
5.3.1 Global Artificial Pancreas Devices Systems Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Artificial Pancreas Devices Systems Sales Value by Application (2019-2030)
5.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application (2019-2030)
6 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY REGION
6.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Artificial Pancreas Devices Systems Sales by Region (2019-2030)
6.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019-2024
6.2.2 Global Artificial Pancreas Devices Systems Sales by Region (2025-2030)
6.3 Global Artificial Pancreas Devices Systems Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Artificial Pancreas Devices Systems Sales Value by Region (2019-2030)
6.4.1 Global Artificial Pancreas Devices Systems Sales Value by Region: 2019-2024
6.4.2 Global Artificial Pancreas Devices Systems Sales Value by Region (2025-2030)
6.5 Global Artificial Pancreas Devices Systems Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.6.2 North America Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.7.2 Europe Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.8.2 Asia-Pacific Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.9.2 Latin America Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Value (2019-2030)
6.10.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Value Share by Country, 2023 VS 2030
7 ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET BY COUNTRY
7.1 Global Artificial Pancreas Devices Systems Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Artificial Pancreas Devices Systems Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Artificial Pancreas Devices Systems Sales by Country (2019-2030)
7.3.1 Global Artificial Pancreas Devices Systems Sales by Country (2019-2024)
7.3.2 Global Artificial Pancreas Devices Systems Sales by Country (2025-2030)
7.4 Global Artificial Pancreas Devices Systems Sales Value by Country (2019-2030)
7.4.1 Global Artificial Pancreas Devices Systems Sales Value by Country (2019-2024)
7.4.2 Global Artificial Pancreas Devices Systems Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.5.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.6.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.7.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.8.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.9.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.10.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.11.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.12.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.13.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.14.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.15.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.16.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.17.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.18.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.19.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.20.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.21.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.22.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Artificial Pancreas Devices Systems Sales Value Growth Rate (2019-2030)
7.23.2 Global Artificial Pancreas Devices Systems Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Bigfoot Biomedical
8.2.1 Bigfoot Biomedical Comapny Information
8.2.2 Bigfoot Biomedical Business Overview
8.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
8.2.5 Bigfoot Biomedical Recent Developments
8.3 Beta Bionics
8.3.1 Beta Bionics Comapny Information
8.3.2 Beta Bionics Business Overview
8.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
8.3.5 Beta Bionics Recent Developments
8.4 Admetsys
8.4.1 Admetsys Comapny Information
8.4.2 Admetsys Business Overview
8.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
8.4.5 Admetsys Recent Developments
8.5 Insulet
8.5.1 Insulet Comapny Information
8.5.2 Insulet Business Overview
8.5.3 Insulet Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
8.5.5 Insulet Recent Developments
8.6 Tandem Diabetes Care
8.6.1 Tandem Diabetes Care Comapny Information
8.6.2 Tandem Diabetes Care Business Overview
8.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
8.6.5 Tandem Diabetes Care Recent Developments
8.7 Defymed
8.7.1 Defymed Comapny Information
8.7.2 Defymed Business Overview
8.7.3 Defymed Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2019-2024)
8.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
8.7.5 Defymed Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Artificial Pancreas Devices Systems Value Chain Analysis
9.1.1 Artificial Pancreas Devices Systems Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Artificial Pancreas Devices Systems Sales Mode & Process
9.2 Artificial Pancreas Devices Systems Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Artificial Pancreas Devices Systems Distributors
9.2.3 Artificial Pancreas Devices Systems Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
